Researchers in Spain have determined how a transcription factor known as Mirror regulates tumour-like growth in the intestines of fruit flies.
The scientists believe a related system may be at work in humans during the progression of colorectal cancer due to the observation of similar genes and genetic interactions in cultured colorectal cancer cells. The results are reported in the journal EMBO Reports.
The image shows a close up of a tumor-like growth (green fluorescence) in the gut of a fruit fly.
Credit: Andreu Casali
Colorectal cancer leads to more than half a million deaths worldwide each year. The disease originates in the epithelial cells of the gastrointestinal track mainly due to aberrations in the molecular signaling activities of cells.
"We have been able to use flies as a model system to study molecular events that are very similar to the steps that take place in colorectal cancer in humans and we have been able to use this system to identify new genetic regulations relevant to human disease," says Andreu Casali, lead author of the study and a research associate at the Institute for Research in Biomedicine in Barcelona.
Mutations in two signalling pathways – the Wnt and EGFR/Ras pathways – are known to activate tumour-like growths in the intestines of fruit flies. In Drosophila, the researchers were able to show that activity of the Decapentaplegic (Dpp) pathway suppresses the growth of these intestinal tumours but that this suppression is counteracted by the Mirror transcription factor, a specific type of Irx transcription factor.
In humans, the equivalent of Dpp is bone morphogenetic protein, a component of the Transforming Growth Factor-beta signaling pathway. "Our results in fruit flies lead us to think that Irx transcription factors such as Mirror might play a similar role in flies and humans, namely reducing the ability of tumour cells to respond to Transforming Growth Factor-beta in the transition from a benign adenoma to more aggressive carcinoma in the human colon," says Casali.
Transforming Growth Factor-beta typically acts as a brake on cell growth in the signaling system of the cell. Therefore Irx transcription factors like Mirror may be responsible under certain conditions for favouring cell growth and leading to cell proliferation that is consistent with the hallmarks of cancer in flies and humans. It may now be possible to test possible interventions for these cancer-like processes using the fly as a model system.
Iro/Irx transcription factors negatively regulate Dpp/TGF-beta pathway activity during intestinal tumorigenesis
Òscar Martorell, Francisco M. Barriga, Anna Merlos-Suárez, Camille Stephan-Otto Attolini, Jordi Casanova, Eduard Batlle, Elena Sancho and Andreu Casali
Head | Public Relations and Communications
Senior Editor, EMBO reports
Tel: +49 6221 8891 305
EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.
EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe.
For more information: http://www.embo.org
Barry Whyte | Eurek Alert!
Discovery of a Key Regulatory Gene in Cardiac Valve Formation
24.05.2017 | Universität Basel
Carcinogenic soot particles from GDI engines
24.05.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.
In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...
23.05.2017 | Event News
22.05.2017 | Event News
17.05.2017 | Event News
24.05.2017 | Earth Sciences
24.05.2017 | Life Sciences
24.05.2017 | Life Sciences